← Leaderboards
Jeffrey Glenn
Stanford University
$26,017,226
Attributed
$26,017,226
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $14.3M · FY2020–25$20M$15M$10M$5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,017,226 · 1
By mechanism
N01$26,017,226 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Jeffrey S Glenn$57,102,148
- David A. Benaron$15,666,167
- Mark Mercola$44,191,191
- Stephen Loen Reichow$24,136,273
- Jan E Carette$15,833,982
Others in their field
Other Emerging Leaders on “Therapeutic Candidate”
- Urs Ochsner · Crestone, Inc.$40,390,611
- Ryan Cirz · Revagenix, Inc.$40,209,479
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Jinhong Chang · Baruch S. Blumberg Institute$16,016,617
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$15,645,835
Research focus
Therapeutic CandidateResearch And DevelopmentProduct DevelopmentPathway InteractionsPre-ClinicalTherapeutic DevelopmentChemistryAdvanced DevelopmentNational Institute Of Allergy And Infectious DiseaseCategoriesCovid-19Efficacy EvaluationEmerging Communicable DiseasesPriority PathogenSafety AssessmentManufactureSafetyCovid-19 TherapeuticsEnterovirus2019-Ncov